Matches in Wikidata for { <http://www.wikidata.org/entity/Q57814122> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q57814122 description "article scientifique publié en 2018" @default.
- Q57814122 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q57814122 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57814122 description "scientific article published on 16 October 2018" @default.
- Q57814122 description "wetenschappelijk artikel" @default.
- Q57814122 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57814122 name "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 name "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 type Item @default.
- Q57814122 label "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 label "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 prefLabel "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 prefLabel "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 P1433 Q57814122-E379E44D-5380-49BD-A46E-70EF82EFC1FA @default.
- Q57814122 P1476 Q57814122-D216F6FB-CFB4-4B6B-85C8-226589168B57 @default.
- Q57814122 P2093 Q57814122-1733B2CC-9022-44B6-8E70-488FD40A8632 @default.
- Q57814122 P2093 Q57814122-268092AB-4912-480E-8219-C069686CA33D @default.
- Q57814122 P2093 Q57814122-7CCD0016-FA96-4B4A-BE96-CD591813DC81 @default.
- Q57814122 P304 Q57814122-83CCFA0C-7E43-4303-B147-FF2B51004314 @default.
- Q57814122 P31 Q57814122-D29C37DA-BC2B-420B-96AC-036D9D4B27F0 @default.
- Q57814122 P356 Q57814122-122BB0E8-A6CD-4CDE-8498-1A100C9F005B @default.
- Q57814122 P407 Q57814122-B0CC0DB8-1BEE-4A51-AC78-D102844B165D @default.
- Q57814122 P478 Q57814122-9F72930B-386C-4646-8967-AE59A4A4C112 @default.
- Q57814122 P50 Q57814122-01BE6BCF-55FD-4584-85FC-1FDB393866AF @default.
- Q57814122 P50 Q57814122-606F991D-1AF0-4FCB-BD71-E85A9D45C494 @default.
- Q57814122 P577 Q57814122-17F6CAA3-8B6C-4812-8711-9613F189BA53 @default.
- Q57814122 P698 Q57814122-55AE000B-87FC-4B34-9FA3-B36FDAE88711 @default.
- Q57814122 P356 J.CTARC.2018.10.001 @default.
- Q57814122 P698 30347333 @default.
- Q57814122 P1433 Q68171835 @default.
- Q57814122 P1476 "Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients" @default.
- Q57814122 P2093 "Karim Fizazi" @default.
- Q57814122 P2093 "Ludovic Doucet" @default.
- Q57814122 P2093 "Stéphane Culine" @default.
- Q57814122 P304 "37-42" @default.
- Q57814122 P31 Q13442814 @default.
- Q57814122 P356 "10.1016/J.CTARC.2018.10.001" @default.
- Q57814122 P407 Q1860 @default.
- Q57814122 P478 "17" @default.
- Q57814122 P50 Q86170386 @default.
- Q57814122 P50 Q88873261 @default.
- Q57814122 P577 "2018-10-16T00:00:00Z" @default.
- Q57814122 P698 "30347333" @default.